Clinical Trials
6 trialsNCT02454075 2021-01-29
YF476 and Type II Gastric Carcinoids
Trio Medicines Ltd.
Phase 2 Terminated
NCT00454363 2020-04-03
Pazopanib Hydrochloride in Treating Patients With Advanced Neuroendocrine Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT02153398 2017-01-19
A Phase I/III Study of D961H 10 mg and 20 mg in Japanese Paediatric Patients With Gastrointestinal Acid Related Diseases
AstraZeneca
Phase 3 Completed
NCT00869050 2016-07-25
Capecitabine and Temozolomide for Neuroendocrine Cancers
Columbia University
Phase 2 Completed
NCT00204373 2012-10-30
Treatment of Zollinger-Ellison Syndrome With Prevacid
University of Alabama at Birmingham
Phase 4 Completed
NCT00942175 2012-02-03
A Study of the Effects of Multiple Doses of Dexlansoprazole, Lansoprazole, Omeprazole or Esomeprazole on the Pharmacokinetics and Pharmacodynamics of Clopidogrel in Healthy Participants.
Takeda
Phase 1 Completed